Research Bronchoscopies in Critically Ill Research Participants: An Official American Thoracic Society Workshop Report.

"Author Disclosures: E.L.B. received research support from Humanetics, NIH/NIAAA, and Quantum Leap Healthcare. R.P.D. served on advisory committee for Prevada Medical; has financial stake in Sequal. K.J.M. received research support from NIH. A.J.S. received research support from Aerogen, Becton Dickinson Biosciences, and Partner Therapeutics. B.D.S. served on scientific advisory board for Zoe Biosciences; holds patent no. US 10,905,706 B2; received research support from NIH. R.D.S. served on data safety and monitoring board for Altimmune; served as consultant for CSL Behring. D.C.F. served on data safety and monitoring board for Medpace; served as consultant for Cytovale and Global Blood Therapeutics; received research support from NIH. C.M., L.A.F., J.B., L.L.C., S.K.C., F.A., F.L., K.M., L.M.-N., and C.H.W. reported no commercial or relevant non-commercial interests from ineligible companies."

"This document was funded by the American Thoracic Society. The views expressed in this article are those of the authors and do not reflect the views of the United States Government, the Department of Veterans Affairs, the funders, the sponsors, or any of the authors’ affiliated academic institutions. A.J.S. is a National Institute for Health Research Senior Investigator. The views expressed in this article are those of the author(s) and not necessarily those of the National Institute for Health Research or the Department of Health and Social Care. Author Disclosures: E.L.B. received research support from Humanetics, NIH/NIAAA, and Quantum Leap Healthcare. R.P.D. served on advisory committee for Prevada Medical; has financial stake in Sequal. K.J.M. received research support from NIH. A.J.S. received research support from Aerogen, Becton Dickinson Biosciences, and Partner Therapeutics. B.D.S. served on scientific advisory board for Zoe Biosciences; holds patent no. US 10,905,706 B2; received research support from NIH. R.D.S. served on data safety and monitoring board for Altimmune; served as consultant for CSL Behring. D.C.F. served on data safety and monitoring board for Medpace; served as consultant for Cytovale and Global Blood Therapeutics; received research support from NIH. C.M., L.A.F., J.B., L.L.C., S.K.C., F.A., F.L., K.M., L.M.-N., and C.H.W. reported no commercial or relevant non-commercial interests from ineligible companies."